1. Home
  2. VRDN vs IREN Comparison

VRDN vs IREN Comparison

Compare VRDN & IREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • IREN
  • Stock Information
  • Founded
  • VRDN 2006
  • IREN 2018
  • Country
  • VRDN United States
  • IREN Australia
  • Employees
  • VRDN N/A
  • IREN N/A
  • Industry
  • VRDN Medical Specialities
  • IREN EDP Services
  • Sector
  • VRDN Health Care
  • IREN Technology
  • Exchange
  • VRDN Nasdaq
  • IREN Nasdaq
  • Market Cap
  • VRDN 1.6B
  • IREN 1.4B
  • IPO Year
  • VRDN N/A
  • IREN 2021
  • Fundamental
  • Price
  • VRDN $12.39
  • IREN $7.04
  • Analyst Decision
  • VRDN Buy
  • IREN Strong Buy
  • Analyst Count
  • VRDN 14
  • IREN 11
  • Target Price
  • VRDN $36.82
  • IREN $19.30
  • AVG Volume (30 Days)
  • VRDN 887.1K
  • IREN 13.1M
  • Earning Date
  • VRDN 05-06-2025
  • IREN 05-14-2025
  • Dividend Yield
  • VRDN N/A
  • IREN N/A
  • EPS Growth
  • VRDN N/A
  • IREN N/A
  • EPS
  • VRDN N/A
  • IREN N/A
  • Revenue
  • VRDN $302,000.00
  • IREN $285,765,000.00
  • Revenue This Year
  • VRDN N/A
  • IREN $183.61
  • Revenue Next Year
  • VRDN $20,553.29
  • IREN $80.31
  • P/E Ratio
  • VRDN N/A
  • IREN N/A
  • Revenue Growth
  • VRDN 4.86
  • IREN 133.25
  • 52 Week Low
  • VRDN $9.90
  • IREN $4.65
  • 52 Week High
  • VRDN $27.20
  • IREN $15.92
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 42.19
  • IREN 58.89
  • Support Level
  • VRDN $11.76
  • IREN $6.01
  • Resistance Level
  • VRDN $13.63
  • IREN $6.63
  • Average True Range (ATR)
  • VRDN 0.75
  • IREN 0.38
  • MACD
  • VRDN -0.02
  • IREN 0.17
  • Stochastic Oscillator
  • VRDN 22.11
  • IREN 87.04

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

About IREN Iris Energy Limited

IREN Ltd is engaged in data center business powering the future of Bitcoin, AI and beyond utilizing renewable energy.

Share on Social Networks: